Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 67

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 67
---
discussions with STAAR’s management and representatives of Citi, the Board was of the view that there was unlikely to be a third party who would be able or willing to provide greater value for STAAR’s stockholders on a timeline similar
to the timeline Alcon was prepared to pursue to execute definitive agreements. Accordingly, the Board directed STAAR’s management to continue exploratory discussions with Alcon, provided that Alcon was willing to offer a high per share price.
The Board then discussed how STAAR’s stockholders, including Stockholder A, may view a transaction with Alcon.

On July 7,
2025, Mr. Farrell wrote Mr. Endicott to request a meeting to discuss the Board’s reaction to Mr. Endicott’s verbal proposal.

On July 8, 2025, Mr. Farrell met with Mr. Endicott in person in Fort Worth, Texas, to discuss the potential transaction and to
indicate that the Board had determined that a premium to STAAR’s stock price of $16.83 on June 26 in excess of 50% would be required for STAAR to engage in additional discussions regarding a potential transaction with Alcon.

On July 9, 2025, Mr. Endicott sent Mr. Farrell a letter setting forth certain terms under which Alcon would acquire all of the
outstanding shares of STAAR common stock for $27.00 per share in cash (the “July 9 Offer”). On July 9, 2025, the trading price of STAAR common stock closed at $17.14 per share, and accordingly, the July 9 Offer represented an
approximately 58% premium to such closing price.

On July 9 and July 10, 2025, Mr. Farrell conveyed the July 9 Offer
to the Board and engaged in discussions with each of the directors. Based on their feedback, Mr. Farrell indicated to the directors that he would seek a higher purchase price, and that if Alcon agreed to a purchase price that the Board
determined to be acceptable, he would plan to engage in discussions with Stockholder A. Mr. Farrell further noted that the confidentiality agreement with Alcon imposed limitations on the information that could be shared with Stockholder A.

On July 11, 2025, Mr. Farrell informed Mr. Endicott that the proposed purchase price of $27.00 per share was insufficient and
that the Board required a purchase price of at least $29.00 per share